Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis-A Study from the FRANCOGYN Group.
Fiche publication
Date publication
mai 2020
Journal
Journal of clinical medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GRAESSLIN Olivier
Tous les auteurs :
Dion L, Mimoun C, Nyangoh Timoh K, Bendifallah S, Bricou A, Collinet P, Touboul C, Ouldamer L, Azaïs H, Dabi Y, Akladios C, Canlorbe G, Bolze PA, Costaz H, Mezzadri M, Gauthier T, Kridelka F, Chauvet P, Bourdel N, Koskas M, Carcopino X, Raimond E, Graesslin O, Lecointre L, Ballester M, Levêque J, Huchon C, Lavoué V
Lien Pubmed
Résumé
Elderly and/or frail women with ovarian cancer are often undertreated. The aim of the study is to compare the effects of age and frailty on surgical approaches, postoperative complications, and prognosis in elderly women with ovarian cancer.
Mots clés
chemotherapy, elderly, frailty, ovarian cancer, surgery
Référence
J Clin Med. 2020 May 4;9(5):